US › Healthcare

Seaport Therapeutics, Inc. Common Stock (SPTX)

US · Healthcare · Biotechnology

$21.43+3.78%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-25.4M

EPS

$-10.34

EPS estimate

$-3.88

EPS came in at -10.34 against a street estimate of -3.88 — a miss of 166.5%.

Key statistics

Market cap

$1.10B

Forward P/E

0.0

P/B

0.00

Book value

$-44.55

EPS (TTM)

$-1.64

52-week high

$23.00

52-week low

$0.01

50-day MA

$19.18

200-day MA

$18.61

Analyst view

with an average price target of $38.00.

Shareholding

Insiders

35.06%

Institutions

36.02%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Seaport Therapeutics, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.